Author
Listed:
- Robert Kleemann
(Laboratory of Biochemistry/Institute for Interfacial Engineering)
- Angelika Hausser
(Institute for Cell Biology and Immunology, University of Stuttgart)
- Georg Geiger
(Laboratory of Biochemistry/Institute for Interfacial Engineering)
- Ralf Mischke
(Laboratory of Biochemistry/Institute for Interfacial Engineering)
- Anke Burger-Kentischer
(Laboratory of Biochemistry/Institute for Interfacial Engineering)
- Oliver Flieger
(Laboratory of Biochemistry/Institute for Interfacial Engineering)
- Franz-Josef Johannes
(Fraunhofer IGB)
- Thierry Roger
(Division of Infectious Diseases Centre Hospitalier Universitaire Vaudois)
- Thierry Calandra
(Division of Infectious Diseases Centre Hospitalier Universitaire Vaudois)
- Aphrodite Kapurniotu
(Physiological-chemical Institute, University of Tübingen)
- Matthias Grell
(Institute for Cell Biology and Immunology, University of Stuttgart
Merck KGaA, Preclinical Research Oncology)
- Doris Finkelmeier
(Laboratory of Biochemistry/Institute for Interfacial Engineering)
- Herwig Brunner
(Laboratory of Biochemistry/Institute for Interfacial Engineering)
- Jürgen Bernhagen
(Laboratory of Biochemistry/Institute for Interfacial Engineering)
Abstract
Cytokines are multifunctional mediators that classically modulate immune activity by receptor-mediated pathways. Macrophage migration inhibitory factor (MIF) is a cytokine that has a critical role in several inflammatory conditions1,2,3 but that also has endocrine4,5 and enzymatic functions6,7. The molecular targets of MIF action have so far remained unclear. Here we show that MIF specifically interacts with an intracellular protein, Jab1, which is a coactivator of AP-1 transcription8,9 that also promotes degradation of the cyclin-dependent kinase inhibitor p27Kip1 (ref. 10). MIF colocalizes with Jab1 in the cytosol, and both endogenous and exogenously added MIF following endocytosis bind Jab1. MIF inhibits Jab1- and stimulus-enhanced AP-1 activity, but does not interfere with the induction of the transcription factor NFκB. Jab1 activates c-Jun amino-terminal kinase (JNK) activity and enhances endogenous phospho-c-Jun levels, and MIF inhibits these effects. MIF also antagonizes Jab1-dependent cell-cycle regulation by increasing p27Kip1 expression through stabilization of p27Kip1 protein. Consequently, Jab1-mediated rescue of fibroblasts from growth arrest is blocked by MIF. Amino acids 50–65 and Cys 60 of MIF are important for Jab1 binding and modulation. We conclude that MIF may act broadly to negatively regulate Jab1-controlled pathways and that the MIF–Jab1 interaction may provide a molecular basis for key activities of MIF.
Suggested Citation
Robert Kleemann & Angelika Hausser & Georg Geiger & Ralf Mischke & Anke Burger-Kentischer & Oliver Flieger & Franz-Josef Johannes & Thierry Roger & Thierry Calandra & Aphrodite Kapurniotu & Matthias G, 2000.
"Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1,"
Nature, Nature, vol. 408(6809), pages 211-216, November.
Handle:
RePEc:nat:nature:v:408:y:2000:i:6809:d:10.1038_35041591
DOI: 10.1038/35041591
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:408:y:2000:i:6809:d:10.1038_35041591. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.